Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$864M |
| 2 |
UnitedHealth
UNH
|
$529M |
| 3 |
Costco
COST
|
$505M |
| 4 |
Atlassian
TEAM
|
$441M |
| 5 |
Northrop Grumman
NOC
|
$353M |
Top Sells
| 1 |
Nike
NKE
|
$447M |
| 2 |
Airbnb
ABNB
|
$404M |
| 3 |
TSMC
TSM
|
$359M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$294M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$199M |
Sector Composition
| 1 | Technology | 27.29% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.35% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
National Vision
EYE
$1.86B
| $15.1M | 0.02% |
463,083
-14,486
| -3% | -$473K |
|
352
Burlington
BURL
$18.4B
| $15.1M | 0.02% |
134,911
-25,597
| -16% | -$2.86M |
|
353
Rush Enterprises Class A
RUSHA
$4.53B
| $15.1M | 0.02% |
515,838
-847,437
| -62% | -$24.8M |
|
354
Wintrust Financial
WTFC
$9.34B
| $15.1M | 0.02% |
184,739
-196,842
| -52% | -$16.1M |
|
355
Neurocrine Biosciences
NBIX
$14.3B
| $15M | 0.01% |
141,330
+2,214
| +2% | +$235K |
|
|
MMP
356
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $14.9M | 0.01% |
314,085
-63,099
| -17% | -$3M |
|
357
ON Semiconductor
ON
$20.1B
| $14.7M | 0.01% |
236,323
-4,240
| -2% | -$264K |
|
358
BCE
BCE
$23.1B
| $14.5M | 0.01% |
347,231
+4,642
| +1% | +$194K |
|
359
Keurig Dr Pepper
KDP
$38.9B
| $14.4M | 0.01% |
403,096
+3,759
| +0.9% | +$135K |
|
360
Integra LifeSciences
IART
$1.25B
| $14.4M | 0.01% |
340,365
+64,963
| +24% | +$2.75M |
|
|
RCM
361
DELISTED
R1 RCM Inc. Common Stock
RCM
| $14.1M | 0.01% |
760,380
+23,963
| +3% | +$444K |
|
362
Caterpillar
CAT
$198B
| $14M | 0.01% |
85,471
+34,980
| +69% | +$5.74M |
|
363
First Foundation Inc
FFWM
$502M
| $14M | 0.01% |
769,811
-329,518
| -30% | -$5.98M |
|
364
Service Corp International
SCI
$10.9B
| $13.9M | 0.01% |
240,098
+2,313
| +1% | +$134K |
|
365
BioLife Solutions
BLFS
$1.27B
| $13.7M | 0.01% |
603,427
+147,324
| +32% | +$3.35M |
|
366
Chewy
CHWY
$17.5B
| $13.6M | 0.01% |
444,021
+24,780
| +6% | +$761K |
|
367
Canadian National Railway
CNI
$60.3B
| $13.6M | 0.01% |
126,031
+179
| +0.1% | +$19.3K |
|
368
Kinetik
KNTK
$2.58B
| $13.5M | 0.01% |
415,083
+142,274
| +52% | +$4.64M |
|
|
BRKL
369
DELISTED
Brookline Bancorp
BRKL
| $13.5M | 0.01% |
1,160,597
-618,837
| -35% | -$7.21M |
|
|
FOCS
370
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $13.2M | 0.01% |
419,697
-220,599
| -34% | -$6.95M |
|
371
Dow Inc
DOW
$17.4B
| $13.2M | 0.01% |
299,380
-794
| -0.3% | -$34.9K |
|
372
Sweetgreen
SG
$1.06B
| $12.7M | 0.01% |
687,033
+250,832
| +58% | +$4.64M |
|
373
Freeport-McMoran
FCX
$66.5B
| $12.7M | 0.01% |
464,289
-3,610
| -0.8% | -$98.7K |
|
374
AvalonBay Communities
AVB
$27.8B
| $12.4M | 0.01% |
67,203
-36,224
| -35% | -$6.67M |
|
375
iShares Russell 1000 Growth ETF
IWF
$117B
| $12M | 0.01% |
56,882
-147,124
| -72% | -$31M |
|